虚拟现实技术联合重复经颅磁刺激治疗对脊髓损伤患者神经病理性疼痛和运动功能及负性情绪的影响OA
Effects of virtual reality combined with repetitive transcranial magnetic stimulation on neuropathic pain,motor function and negative emotions in patients with spinal cord injury
目的 观察虚拟现实(VR)技术联合重复经颅磁刺激(rTMS)治疗对脊髓损伤(SCI)患者神经病理性疼痛、运动功能及负性情绪的影响.方法 选取2023年11月至2024年11月于开封市中心医院康复医学科住院治疗的SCI伴神经病理性疼痛患者90例.根据随机数表法分为观察组和对照组,每组45例.对照组采用常规康复方法,观察组在对照组康复治疗基础上联合VR训练和rTMS治疗,疗程均为8周.比较两组临床疗效、疼痛情况、下肢运动功能、负性情绪发生情况及血清学指标,记录治疗期间不良反应及随访6个月的疼痛视觉模拟评分法(VAS)评分.结果 观察组治疗总有效率为91.11%,高于对照组(68.89%;χ2=6.944,P<0.05).观察组治疗后VAS、医院焦虑抑郁量表的焦虑评分和抑郁评分及血清白介素-6(IL-6)水平均低于对照组[分别为(2.61±1.03)分比(4.28±1.16)分,(7.18±2.31)分比(9.93±2.57)分,(7.44±2.25)分比(10.38±2.49)分,(4.38±1.47)pg/mL比(6.21±1.62)pg/mL;t=7.222、5.338、5.877、5.612,P<0.001],Fugl-Meyer下肢运动功能评定量表、下肢运动功能评分、血清脑源性神经营养因子水平均显著高于对照组[分别为(22.46±3.81)分比(17.18±3.55)分,(28.14±5.29)分比(21.73±5.02)分,(31.24±5.08)pg/mL比(23.59±4.67)pg/mL;t=6.802、5.896、7.437,P<0.001].治疗期间两组不良反应发生率比较,差异无统计学意义(χ2=0.714,P=0.399).治疗结束后6个月,共成功随访85例患者(观察组42例,对照组43例),随访结果显示,观察组VAS评分低于对照组[(3.15±1.18)分比(4.95±1.24)分;t=6.853,P<0.001].结论 VR技术联合rTMS安全有效,有助于缓解SCI患者神经病理性疼痛,改善下肢运动功能,减轻焦虑抑郁情绪,机制可能与其上调血清脑源性神经营养因子水平、下调血清白介素-6水平有关.
Objective To observe the effects of virtual reality(VR)combined with repetitive transcranial magnetic stimulation(rTMS)on neuropathic pain,motor function and negative emotions in patients with spinal cord injury(SCI).Methods A total of 90 patients with SCI complicated by neuropathic pain who were hospitalized in the Department of Rehabilitation Medicine of Kaifeng Central Hospital from November 2023 to November 2024 were selected.All patients were randomly divided into an observation group and a control group based on the random number table method,with 45 cases in each group.The control group received conventional rehabilitation therapy,while the observation group received VR training and rTMS in addition to the conventional rehabilitation therapy.The treatment duration was 8 weeks for both groups.The clinical efficacy,pain status,lower limb motor function,negative emotions,and serological indicators were compared between the two groups.Adverse reactions during treatment and the Visual Analogue Scale(VAS)score at the 6-month follow-up were recorded.Results The total effective rate in the observation group was 91.11%,which was higher than that in the control group(68.89%;χ2=6.944,P<0.05).After treatment,the VAS score,the anxiety and depression scores of the Hospital Anxiety and Depression Scale(HADS)-Anxiety(HADS-A)and serum interleukin-6(IL-6)level in the observation group were lower lower than the control group[(2.61±1.03)points vs.(4.28±1.16)points,(7.18±2.31)points vs.(9.93±2.57)points,(7.44±2.25)points vs.(10.38±2.49)points,(4.38±1.47)pg/mL vs.(6.21±1.62)pg/mL;t=7.222,5.338,5.877,5.612,P<0.001].While,the Fugl-Meyer Assessment of Lower Extremity Motor Function(FMA-LE)score,Lower Extremity Motor Score(LEMS)and serum brain-derived neurotrophic factor(BDNF)level in the observation group were higher than those in the control group[(22.46±3.81)points vs.(17.18±3.55)points,(28.14±5.29)points vs.(21.73±5.02)points,(31.24±5.08)pg/mL vs.(23.59±4.67)pg/mL;t=6.802,5.896,7.437,P<0.001].During the treatment period,there was no statistically significant difference in the incidence of adverse reactions between the two groups(χ2=0.714,P=0.399).At 6 months after the end of treatment,a total of 85 patients were successfully followed up,(42 in the observation group and 43 in the control group).The follow-up results showed that the VAS score in the observation group was lower than that in the control group[(3.15±1.18)points vs.(4.95±1.24)points;t=6.853,P<0.001].Conclusions VR combined with rTMS is safe and effective,helping to alleviate neuropathic pain,improve lower extremity motor function,and reduce anxiety and depression in SCI patients.The mechanism may be related to upregulation of serum BDNF levels and downregulation of IL-6 levels.
时洋;杨俊涛;杨鑫
开封市中心医院康复医学科治疗部,河南 开封 475000开封市中心医院康复医学科治疗部,河南 开封 475000开封市中心医院康复医学科治疗部,河南 开封 475000
脊髓损伤神经病理性疼痛虚拟现实技术重复经颅磁刺激运动功能焦虑抑郁
spinal cord injuryneuropathic painvirtual realityrepetitive transcranial magnetic stimulationmotor functionanxietydepression
《感染、炎症、修复》 2026 (4)
363-368,6
评论